247 related articles for article (PubMed ID: 23315907)
1. Association between resting heart rate, chronotropic index, and long-term outcomes in patients with heart failure receiving β-blocker therapy: data from the HF-ACTION trial.
Dobre D; Zannad F; Keteyian SJ; Stevens SR; Rossignol P; Kitzman DW; Landzberg J; Howlett J; Kraus WE; Ellis SJ
Eur Heart J; 2013 Aug; 34(29):2271-80. PubMed ID: 23315907
[TBL] [Abstract][Full Text] [Related]
2. Effect of β-blocker cessation on chronotropic incompetence and exercise tolerance in patients with advanced heart failure.
Hirsh BJ; Mignatti A; Garan AR; Uriel N; Colombo P; Sims DB; Jorde UP
Circ Heart Fail; 2012 Sep; 5(5):560-5. PubMed ID: 22855557
[TBL] [Abstract][Full Text] [Related]
3. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial.
Fiuzat M; Wojdyla D; Pina I; Adams K; Whellan D; O'Connor CM
JACC Heart Fail; 2016 Feb; 4(2):109-115. PubMed ID: 26519996
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
[TBL] [Abstract][Full Text] [Related]
5. Association of β-Blocker Use With Heart Failure Hospitalizations and Cardiovascular Disease Mortality Among Patients With Heart Failure With a Preserved Ejection Fraction: A Secondary Analysis of the TOPCAT Trial.
Silverman DN; Plante TB; Infeld M; Callas PW; Juraschek SP; Dougherty GB; Meyer M
JAMA Netw Open; 2019 Dec; 2(12):e1916598. PubMed ID: 31800067
[TBL] [Abstract][Full Text] [Related]
6. Insufficient reduction in heart rate during hospitalization despite beta-blocker treatment in acute decompensated heart failure: insights from the ASCEND-HF trial.
Kitai T; Grodin JL; Mentz RJ; Hernandez AF; Butler J; Metra M; McMurray JJ; Armstrong PW; Starling RC; O'Connor CM; Swedberg K; Tang WH
Eur J Heart Fail; 2017 Feb; 19(2):241-249. PubMed ID: 27634557
[TBL] [Abstract][Full Text] [Related]
7. Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention.
Fukase T; Dohi T; Koike T; Yasuda H; Takeuchi M; Takahashi N; Chikata Y; Endo H; Doi S; Nishiyama H; Okai I; Iwata H; Okazaki S; Miyauchi K; Daida H; Minamino T
ESC Heart Fail; 2022 Feb; 9(1):545-554. PubMed ID: 34811932
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
[TBL] [Abstract][Full Text] [Related]
9. Resting Heart Rate and Chronotropic Response to Exercise: Prognostic Implications in Heart Failure Across the Left Ventricular Ejection Fraction Spectrum.
Santos M; West E; Skali H; Forman DE; Nadruz W; Shah AM
J Card Fail; 2018 Nov; 24(11):753-762. PubMed ID: 30300684
[TBL] [Abstract][Full Text] [Related]
10. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.
Witte KK; Cleland JG; Clark AL
Heart; 2006 Apr; 92(4):481-6. PubMed ID: 16159968
[TBL] [Abstract][Full Text] [Related]
11. β-Blockers and 1-Year Postdischarge Mortality for Heart Failure and Reduced Ejection Fraction and Slow Discharge Heart Rate.
Park JJ; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
J Am Heart Assoc; 2019 Feb; 8(4):e011121. PubMed ID: 30755071
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
Li S; Li X
High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
[TBL] [Abstract][Full Text] [Related]
13. Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction.
Ibrahim NE; Gaggin HK; Turchin A; Patel HK; Song Y; Trebnick A; Doros G; Maya JF; Cannon CP; Januzzi JL
Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):3-11. PubMed ID: 29490032
[TBL] [Abstract][Full Text] [Related]
14. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
15. β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Zhou H; Sim JJ; Shi J; Shaw SF; Lee MS; Neyer JR; Kovesdy CP; Kalantar-Zadeh K; Jacobsen SJ
Am J Kidney Dis; 2021 May; 77(5):704-712. PubMed ID: 33010357
[TBL] [Abstract][Full Text] [Related]
16. Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillation.
Kao DP; Davis G; Aleong R; O'Connor CM; Fiuzat M; Carson PE; Anand IS; Plehn JF; Gottlieb SS; Silver MA; Lindenfeld J; Miller AB; White M; Murphy GA; Sauer W; Bristow MR
Eur J Heart Fail; 2013 Mar; 15(3):324-33. PubMed ID: 23223178
[TBL] [Abstract][Full Text] [Related]
17. Exercise Ventricular Rates, Cardiopulmonary Exercise Performance, and Mortality in Patients With Heart Failure With Atrial Fibrillation.
Elshazly MB; Wilkoff BL; Tarakji K; Wu Y; Donnellan E; Abi Khalil C; Asaad N; Jaber W; Wazni O; Cho L
Circ Heart Fail; 2021 Feb; 14(2):e007451. PubMed ID: 33478244
[TBL] [Abstract][Full Text] [Related]
18. Resting heart rate and heart rate reserve in advanced heart failure have distinct pathophysiologic correlates and prognostic impact: a prospective pilot study.
Benes J; Kotrc M; Borlaug BA; Lefflerova K; Jarolim P; Bendlova B; Jabor A; Kautzner J; Melenovsky V
JACC Heart Fail; 2013 Jun; 1(3):259-66. PubMed ID: 24621878
[TBL] [Abstract][Full Text] [Related]
19. Heart rate recovery--a potential marker of clinical outcomes in heart failure patients receiving beta-blocker therapy.
Sheppard RJ; Racine N; Roof A; Ducharme A; Blanchet M; White M
Can J Cardiol; 2007 Dec; 23(14):1135-8. PubMed ID: 18060099
[TBL] [Abstract][Full Text] [Related]
20. Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions.
Verbrugge FH; Duchenne J; Bertrand PB; Dupont M; Tang WH; Mullens W
Am J Cardiol; 2013 Dec; 112(12):1913-20. PubMed ID: 24286620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
